| Literature DB >> 12747794 |
Mark S Chambers1, John R Atack, Howard B Broughton, Neil Collinson, Susan Cook, Gerard R Dawson, Sarah C Hobbs, George Marshall, Karen A Maubach, Goplan V Pillai, Austin J Reeve, Angus M MacLeod.
Abstract
In pursuit of a GABA(A) alpha5-subtype-selective inverse agonist to enhance cognition, a series of 6,7-dihydro-2-benzothiophen-4(5H)-ones has been identified as a novel class of GABA(A) receptor ligands. These thiophenes have higher binding affinity for the GABA(A) alpha5 receptor subtype compared to the GABA(A) alpha1, alpha2, and alpha3 subtypes, and several analogues exhibit high GABA(A) alpha5 receptor inverse agonism. 6,6-Dimethyl-3-(2-hydroxyethyl)thio-1-(thiazol-2-yl)-6,7-dihydro-2-benzothiophen-4(5H)-one (43) has been identified as a full inverse agonist at the GABA(A) alpha5 receptor and is functionally selective over the other major GABA(A) receptor subtypes. 43 readily penetrates into the CNS to give selective occupancy of GABA(A) alpha5 receptors. In addition, 43 enhances cognitive performance in rats in the delayed 'matching-to-place' Morris water maze test-a hippocampal-dependent memory task-without the convulsant or proconvulsant activity associated with nonselective, GABA(A) receptor inverse agonists.Entities:
Mesh：
Substances：
Year: 2003 PMID： 12747794 DOI： 10.1021/jm020582q
Source DB: PubMed Journal: J Med Chem ISSN： 0022-2623 Impact factor: 7.446